nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0504	0.21	CbGbCtD
Carfilzomib—ABCB1—Betamethasone—rheumatoid arthritis	0.0328	0.137	CbGbCtD
Carfilzomib—ABCB1—Prednisolone—rheumatoid arthritis	0.0324	0.135	CbGbCtD
Carfilzomib—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0307	0.128	CbGbCtD
Carfilzomib—ABCB1—Prednisone—rheumatoid arthritis	0.0306	0.127	CbGbCtD
Carfilzomib—ABCB1—Cyclosporine—rheumatoid arthritis	0.029	0.121	CbGbCtD
Carfilzomib—ABCB1—Dexamethasone—rheumatoid arthritis	0.0191	0.0794	CbGbCtD
Carfilzomib—ABCB1—Methotrexate—rheumatoid arthritis	0.0153	0.0638	CbGbCtD
Carfilzomib—PSMB8—parotid gland—rheumatoid arthritis	0.00768	0.0742	CbGeAlD
Carfilzomib—PSMB10—lymphoid tissue—rheumatoid arthritis	0.00767	0.0741	CbGeAlD
Carfilzomib—PSMB10—digestive system—rheumatoid arthritis	0.00758	0.0732	CbGeAlD
Carfilzomib—PSMB8—saliva-secreting gland—rheumatoid arthritis	0.00736	0.071	CbGeAlD
Carfilzomib—PSMB5—parotid gland—rheumatoid arthritis	0.00679	0.0655	CbGeAlD
Carfilzomib—PSMB5—saliva-secreting gland—rheumatoid arthritis	0.0065	0.0628	CbGeAlD
Carfilzomib—PSMB1—parotid gland—rheumatoid arthritis	0.00593	0.0573	CbGeAlD
Carfilzomib—PSMB2—parotid gland—rheumatoid arthritis	0.00579	0.0559	CbGeAlD
Carfilzomib—PSMB1—saliva-secreting gland—rheumatoid arthritis	0.00568	0.0549	CbGeAlD
Carfilzomib—PSMB2—saliva-secreting gland—rheumatoid arthritis	0.00554	0.0535	CbGeAlD
Carfilzomib—PSMB2—connective tissue—rheumatoid arthritis	0.00509	0.0492	CbGeAlD
Carfilzomib—PSMB8—tendon—rheumatoid arthritis	0.00465	0.0449	CbGeAlD
Carfilzomib—PSMB5—tendon—rheumatoid arthritis	0.0041	0.0396	CbGeAlD
Carfilzomib—PSMB1—lymphoid tissue—rheumatoid arthritis	0.00382	0.0369	CbGeAlD
Carfilzomib—PSMB1—digestive system—rheumatoid arthritis	0.00377	0.0364	CbGeAlD
Carfilzomib—PSMB2—lymphoid tissue—rheumatoid arthritis	0.00372	0.036	CbGeAlD
Carfilzomib—PSMB2—digestive system—rheumatoid arthritis	0.00368	0.0355	CbGeAlD
Carfilzomib—PSMB1—tendon—rheumatoid arthritis	0.00359	0.0346	CbGeAlD
Carfilzomib—PSMB2—tendon—rheumatoid arthritis	0.0035	0.0338	CbGeAlD
Carfilzomib—PSMB8—Balsalazide—Sulfasalazine—rheumatoid arthritis	0.00146	0.108	CbGdCrCtD
Carfilzomib—Nausea—Ergocalciferol—rheumatoid arthritis	0.00103	0.0049	CcSEcCtD
Carfilzomib—Hyperglycaemia—Leflunomide—rheumatoid arthritis	0.00102	0.00484	CcSEcCtD
Carfilzomib—Pneumonia—Leflunomide—rheumatoid arthritis	0.00101	0.00482	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisolone—rheumatoid arthritis	0.00101	0.00481	CcSEcCtD
Carfilzomib—Renal failure—Leflunomide—rheumatoid arthritis	0.000991	0.00471	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Hydrocortisone—rheumatoid arthritis	0.00099	0.0047	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Leflunomide—rheumatoid arthritis	0.000989	0.00469	CcSEcCtD
Carfilzomib—Diarrhoea—Auranofin—rheumatoid arthritis	0.000969	0.0046	CcSEcCtD
Carfilzomib—Blood creatinine increased—Cyclosporine—rheumatoid arthritis	0.000946	0.00449	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Triamcinolone—rheumatoid arthritis	0.000932	0.00442	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Methylprednisolone—rheumatoid arthritis	0.00093	0.00441	CcSEcCtD
Carfilzomib—Vomiting—Auranofin—rheumatoid arthritis	0.000901	0.00428	CcSEcCtD
Carfilzomib—Diarrhoea—Penicillamine—rheumatoid arthritis	0.000895	0.00425	CcSEcCtD
Carfilzomib—Oedema peripheral—Leflunomide—rheumatoid arthritis	0.000892	0.00423	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisolone—rheumatoid arthritis	0.000874	0.00415	CcSEcCtD
Carfilzomib—Chills—Azathioprine—rheumatoid arthritis	0.00086	0.00408	CcSEcCtD
Carfilzomib—Cardiac arrest—Hydrocortisone—rheumatoid arthritis	0.000854	0.00405	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Betamethasone—rheumatoid arthritis	0.000846	0.00401	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Dexamethasone—rheumatoid arthritis	0.000846	0.00401	CcSEcCtD
Carfilzomib—Nausea—Auranofin—rheumatoid arthritis	0.000842	0.00399	CcSEcCtD
Carfilzomib—Cardiac disorder—Leflunomide—rheumatoid arthritis	0.00084	0.00399	CcSEcCtD
Carfilzomib—Vomiting—Penicillamine—rheumatoid arthritis	0.000832	0.00395	CcSEcCtD
Carfilzomib—Hypokalaemia—Hydrocortisone—rheumatoid arthritis	0.000817	0.00388	CcSEcCtD
Carfilzomib—Chills—Leflunomide—rheumatoid arthritis	0.000812	0.00386	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Cyclosporine—rheumatoid arthritis	0.000811	0.00385	CcSEcCtD
Carfilzomib—Cardiac arrest—Triamcinolone—rheumatoid arthritis	0.000804	0.00382	CcSEcCtD
Carfilzomib—Cardiac arrest—Methylprednisolone—rheumatoid arthritis	0.000802	0.00381	CcSEcCtD
Carfilzomib—Sepsis—Prednisone—rheumatoid arthritis	0.000798	0.00379	CcSEcCtD
Carfilzomib—Hyperglycaemia—Cyclosporine—rheumatoid arthritis	0.000788	0.00374	CcSEcCtD
Carfilzomib—Pneumonia—Cyclosporine—rheumatoid arthritis	0.000783	0.00372	CcSEcCtD
Carfilzomib—Nausea—Penicillamine—rheumatoid arthritis	0.000777	0.00369	CcSEcCtD
Carfilzomib—Anaemia—Azathioprine—rheumatoid arthritis	0.000771	0.00366	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Cyclosporine—rheumatoid arthritis	0.000767	0.00364	CcSEcCtD
Carfilzomib—Renal failure—Cyclosporine—rheumatoid arthritis	0.000765	0.00363	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Cyclosporine—rheumatoid arthritis	0.000763	0.00362	CcSEcCtD
Carfilzomib—Back pain—Leflunomide—rheumatoid arthritis	0.000762	0.00362	CcSEcCtD
Carfilzomib—Muscle spasms—Leflunomide—rheumatoid arthritis	0.000758	0.0036	CcSEcCtD
Carfilzomib—Leukopenia—Azathioprine—rheumatoid arthritis	0.000747	0.00355	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisone—rheumatoid arthritis	0.000736	0.0035	CcSEcCtD
Carfilzomib—Cardiac arrest—Betamethasone—rheumatoid arthritis	0.000729	0.00346	CcSEcCtD
Carfilzomib—Cardiac arrest—Dexamethasone—rheumatoid arthritis	0.000729	0.00346	CcSEcCtD
Carfilzomib—Anaemia—Leflunomide—rheumatoid arthritis	0.000728	0.00346	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Hydrocortisone—rheumatoid arthritis	0.000721	0.00342	CcSEcCtD
Carfilzomib—Arthralgia—Azathioprine—rheumatoid arthritis	0.000711	0.00337	CcSEcCtD
Carfilzomib—Leukopenia—Leflunomide—rheumatoid arthritis	0.000706	0.00335	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisolone—rheumatoid arthritis	0.000698	0.00331	CcSEcCtD
Carfilzomib—Hypokalaemia—Dexamethasone—rheumatoid arthritis	0.000698	0.00331	CcSEcCtD
Carfilzomib—Hypokalaemia—Betamethasone—rheumatoid arthritis	0.000698	0.00331	CcSEcCtD
Carfilzomib—Hypoaesthesia—Cyclosporine—rheumatoid arthritis	0.000695	0.0033	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisolone—rheumatoid arthritis	0.000694	0.0033	CcSEcCtD
Carfilzomib—Cough—Leflunomide—rheumatoid arthritis	0.000688	0.00326	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Hydrocortisone—rheumatoid arthritis	0.000682	0.00324	CcSEcCtD
Carfilzomib—Hypertension—Leflunomide—rheumatoid arthritis	0.00068	0.00323	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Triamcinolone—rheumatoid arthritis	0.000679	0.00322	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Hydrocortisone—rheumatoid arthritis	0.000678	0.00322	CcSEcCtD
Carfilzomib—Infection—Azathioprine—rheumatoid arthritis	0.000677	0.00321	CcSEcCtD
Carfilzomib—Arthralgia—Leflunomide—rheumatoid arthritis	0.000671	0.00319	CcSEcCtD
Carfilzomib—Sepsis—Methotrexate—rheumatoid arthritis	0.000667	0.00317	CcSEcCtD
Carfilzomib—Thrombocytopenia—Azathioprine—rheumatoid arthritis	0.000667	0.00317	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Triamcinolone—rheumatoid arthritis	0.000642	0.00305	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Methylprednisolone—rheumatoid arthritis	0.000641	0.00304	CcSEcCtD
Carfilzomib—Infection—Leflunomide—rheumatoid arthritis	0.000639	0.00303	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Triamcinolone—rheumatoid arthritis	0.000639	0.00303	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Methylprednisolone—rheumatoid arthritis	0.000637	0.00302	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisone—rheumatoid arthritis	0.000635	0.00301	CcSEcCtD
Carfilzomib—Thrombocytopenia—Leflunomide—rheumatoid arthritis	0.00063	0.00299	CcSEcCtD
Carfilzomib—Chills—Cyclosporine—rheumatoid arthritis	0.000627	0.00298	CcSEcCtD
Carfilzomib—Hepatic failure—Methotrexate—rheumatoid arthritis	0.000621	0.00295	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Azathioprine—rheumatoid arthritis	0.000621	0.00295	CcSEcCtD
Carfilzomib—Anorexia—Leflunomide—rheumatoid arthritis	0.000613	0.00291	CcSEcCtD
Carfilzomib—Hypokalaemia—Prednisone—rheumatoid arthritis	0.000608	0.00289	CcSEcCtD
Carfilzomib—Renal failure acute—Methotrexate—rheumatoid arthritis	0.000605	0.00287	CcSEcCtD
Carfilzomib—Hyperglycaemia—Dexamethasone—rheumatoid arthritis	0.000598	0.00284	CcSEcCtD
Carfilzomib—Hyperglycaemia—Betamethasone—rheumatoid arthritis	0.000598	0.00284	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Leflunomide—rheumatoid arthritis	0.000586	0.00278	CcSEcCtD
Carfilzomib—Muscle spasms—Cyclosporine—rheumatoid arthritis	0.000585	0.00278	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Betamethasone—rheumatoid arthritis	0.000583	0.00277	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Dexamethasone—rheumatoid arthritis	0.000583	0.00277	CcSEcCtD
Carfilzomib—Insomnia—Leflunomide—rheumatoid arthritis	0.000582	0.00276	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Dexamethasone—rheumatoid arthritis	0.000579	0.00275	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Betamethasone—rheumatoid arthritis	0.000579	0.00275	CcSEcCtD
Carfilzomib—Dyspnoea—Leflunomide—rheumatoid arthritis	0.000573	0.00272	CcSEcCtD
Carfilzomib—ABCB1—lymphoid tissue—rheumatoid arthritis	0.000569	0.00549	CbGeAlD
Carfilzomib—Anaemia—Cyclosporine—rheumatoid arthritis	0.000562	0.00267	CcSEcCtD
Carfilzomib—ABCB1—digestive system—rheumatoid arthritis	0.000562	0.00543	CbGeAlD
Carfilzomib—Decreased appetite—Leflunomide—rheumatoid arthritis	0.000559	0.00265	CcSEcCtD
Carfilzomib—Fatigue—Leflunomide—rheumatoid arthritis	0.000555	0.00263	CcSEcCtD
Carfilzomib—Constipation—Leflunomide—rheumatoid arthritis	0.00055	0.00261	CcSEcCtD
Carfilzomib—Pain—Leflunomide—rheumatoid arthritis	0.00055	0.00261	CcSEcCtD
Carfilzomib—Leukopenia—Cyclosporine—rheumatoid arthritis	0.000544	0.00258	CcSEcCtD
Carfilzomib—Cardiac disorder—Methylprednisolone—rheumatoid arthritis	0.000541	0.00257	CcSEcCtD
Carfilzomib—Neutropenia—Prednisone—rheumatoid arthritis	0.00054	0.00256	CcSEcCtD
Carfilzomib—Body temperature increased—Azathioprine—rheumatoid arthritis	0.000538	0.00256	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.000532	0.0394	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.000532	0.0394	CbGdCrCtD
Carfilzomib—Cough—Cyclosporine—rheumatoid arthritis	0.000531	0.00252	CcSEcCtD
Carfilzomib—Hypertension—Cyclosporine—rheumatoid arthritis	0.000525	0.00249	CcSEcCtD
Carfilzomib—Hyperglycaemia—Prednisone—rheumatoid arthritis	0.000521	0.00247	CcSEcCtD
Carfilzomib—Arthralgia—Cyclosporine—rheumatoid arthritis	0.000518	0.00246	CcSEcCtD
Carfilzomib—Body temperature increased—Leflunomide—rheumatoid arthritis	0.000509	0.00241	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisone—rheumatoid arthritis	0.000507	0.00241	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisone—rheumatoid arthritis	0.000505	0.0024	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.000502	0.0372	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.000502	0.0372	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000494	0.0366	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000494	0.0366	CbGdCrCtD
Carfilzomib—Infection—Cyclosporine—rheumatoid arthritis	0.000493	0.00234	CcSEcCtD
Carfilzomib—Back pain—Triamcinolone—rheumatoid arthritis	0.000492	0.00234	CcSEcCtD
Carfilzomib—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	0.000486	0.00231	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Triamcinolone—rheumatoid arthritis	0.000482	0.0357	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Triamcinolone—rheumatoid arthritis	0.000482	0.0357	CbGdCrCtD
Carfilzomib—Hypertension—Prednisolone—rheumatoid arthritis	0.000478	0.00227	CcSEcCtD
Carfilzomib—Anorexia—Cyclosporine—rheumatoid arthritis	0.000473	0.00225	CcSEcCtD
Carfilzomib—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000467	0.00222	CcSEcCtD
Carfilzomib—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000466	0.00221	CcSEcCtD
Carfilzomib—Asthenia—Leflunomide—rheumatoid arthritis	0.000462	0.00219	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisone—rheumatoid arthritis	0.000458	0.0339	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisone—rheumatoid arthritis	0.000458	0.0339	CbGdCrCtD
Carfilzomib—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.000452	0.00215	CcSEcCtD
Carfilzomib—Neutropenia—Methotrexate—rheumatoid arthritis	0.000451	0.00214	CcSEcCtD
Carfilzomib—Dizziness—Azathioprine—rheumatoid arthritis	0.00045	0.00214	CcSEcCtD
Carfilzomib—Insomnia—Cyclosporine—rheumatoid arthritis	0.000449	0.00213	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Methotrexate—rheumatoid arthritis	0.000448	0.00213	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisolone—rheumatoid arthritis	0.000447	0.0331	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisolone—rheumatoid arthritis	0.000447	0.0331	CbGdCrCtD
Carfilzomib—Cough—Triamcinolone—rheumatoid arthritis	0.000444	0.00211	CcSEcCtD
Carfilzomib—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.000443	0.0021	CcSEcCtD
Carfilzomib—Diarrhoea—Leflunomide—rheumatoid arthritis	0.00044	0.00209	CcSEcCtD
Carfilzomib—Hypertension—Triamcinolone—rheumatoid arthritis	0.000439	0.00209	CcSEcCtD
Carfilzomib—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000439	0.00208	CcSEcCtD
Carfilzomib—Infection—Hydrocortisone—rheumatoid arthritis	0.000438	0.00208	CcSEcCtD
Carfilzomib—Vomiting—Azathioprine—rheumatoid arthritis	0.000433	0.00206	CcSEcCtD
Carfilzomib—Pneumonia—Methotrexate—rheumatoid arthritis	0.000433	0.00205	CcSEcCtD
Carfilzomib—Arthralgia—Methylprednisolone—rheumatoid arthritis	0.000432	0.00205	CcSEcCtD
Carfilzomib—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000432	0.00205	CcSEcCtD
Carfilzomib—Fatigue—Cyclosporine—rheumatoid arthritis	0.000428	0.00203	CcSEcCtD
Carfilzomib—Headache—Azathioprine—rheumatoid arthritis	0.000427	0.00203	CcSEcCtD
Carfilzomib—Dizziness—Leflunomide—rheumatoid arthritis	0.000425	0.00202	CcSEcCtD
Carfilzomib—Pain—Cyclosporine—rheumatoid arthritis	0.000425	0.00202	CcSEcCtD
Carfilzomib—Constipation—Cyclosporine—rheumatoid arthritis	0.000425	0.00202	CcSEcCtD
Carfilzomib—Renal failure—Methotrexate—rheumatoid arthritis	0.000423	0.00201	CcSEcCtD
Carfilzomib—Anorexia—Hydrocortisone—rheumatoid arthritis	0.000421	0.002	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Hydrocortisone—rheumatoid arthritis	0.000415	0.0308	CbGdCrCtD
Carfilzomib—Infection—Triamcinolone—rheumatoid arthritis	0.000413	0.00196	CcSEcCtD
Carfilzomib—Infection—Methylprednisolone—rheumatoid arthritis	0.000412	0.00195	CcSEcCtD
Carfilzomib—Vomiting—Leflunomide—rheumatoid arthritis	0.000409	0.00194	CcSEcCtD
Carfilzomib—Insomnia—Prednisolone—rheumatoid arthritis	0.000409	0.00194	CcSEcCtD
Carfilzomib—Nausea—Azathioprine—rheumatoid arthritis	0.000405	0.00192	CcSEcCtD
Carfilzomib—Headache—Leflunomide—rheumatoid arthritis	0.000403	0.00191	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000402	0.00191	CcSEcCtD
Carfilzomib—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000399	0.00189	CcSEcCtD
Carfilzomib—Hypertension—Betamethasone—rheumatoid arthritis	0.000399	0.00189	CcSEcCtD
Carfilzomib—Hypertension—Dexamethasone—rheumatoid arthritis	0.000399	0.00189	CcSEcCtD
Carfilzomib—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000392	0.00186	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Methylprednisolone—rheumatoid arthritis	0.000392	0.029	CbGdCrCtD
Carfilzomib—Pain—Prednisolone—rheumatoid arthritis	0.000386	0.00183	CcSEcCtD
Carfilzomib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000384	0.00182	CcSEcCtD
Carfilzomib—Nausea—Leflunomide—rheumatoid arthritis	0.000382	0.00181	CcSEcCtD
Carfilzomib—Fatigue—Hydrocortisone—rheumatoid arthritis	0.00038	0.00181	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000378	0.0018	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000378	0.00179	CcSEcCtD
Carfilzomib—Pain—Hydrocortisone—rheumatoid arthritis	0.000377	0.00179	CcSEcCtD
Carfilzomib—Insomnia—Triamcinolone—rheumatoid arthritis	0.000376	0.00178	CcSEcCtD
Carfilzomib—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000375	0.00178	CcSEcCtD
Carfilzomib—Infection—Betamethasone—rheumatoid arthritis	0.000374	0.00178	CcSEcCtD
Carfilzomib—Infection—Dexamethasone—rheumatoid arthritis	0.000374	0.00178	CcSEcCtD
Carfilzomib—Anaemia—Prednisone—rheumatoid arthritis	0.000372	0.00176	CcSEcCtD
Carfilzomib—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.00037	0.00176	CcSEcCtD
Carfilzomib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000369	0.00175	CcSEcCtD
Carfilzomib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000369	0.00175	CcSEcCtD
Carfilzomib—Anorexia—Dexamethasone—rheumatoid arthritis	0.000359	0.00171	CcSEcCtD
Carfilzomib—Anorexia—Betamethasone—rheumatoid arthritis	0.000359	0.00171	CcSEcCtD
Carfilzomib—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000358	0.0017	CcSEcCtD
Carfilzomib—Fatigue—Triamcinolone—rheumatoid arthritis	0.000358	0.0017	CcSEcCtD
Carfilzomib—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000357	0.0017	CcSEcCtD
Carfilzomib—Asthenia—Cyclosporine—rheumatoid arthritis	0.000356	0.00169	CcSEcCtD
Carfilzomib—Pain—Triamcinolone—rheumatoid arthritis	0.000355	0.00169	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Prednisolone—rheumatoid arthritis	0.000349	0.0258	CbGdCrCtD
Carfilzomib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000349	0.00166	CcSEcCtD
Carfilzomib—Hypertension—Prednisone—rheumatoid arthritis	0.000347	0.00165	CcSEcCtD
Carfilzomib—Chills—Methotrexate—rheumatoid arthritis	0.000346	0.00164	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000343	0.00163	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000343	0.00163	CcSEcCtD
Carfilzomib—Arthralgia—Prednisone—rheumatoid arthritis	0.000342	0.00163	CcSEcCtD
Carfilzomib—Insomnia—Dexamethasone—rheumatoid arthritis	0.000341	0.00162	CcSEcCtD
Carfilzomib—Insomnia—Betamethasone—rheumatoid arthritis	0.000341	0.00162	CcSEcCtD
Carfilzomib—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00034	0.00161	CcSEcCtD
Carfilzomib—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000328	0.00156	CcSEcCtD
Carfilzomib—Dizziness—Cyclosporine—rheumatoid arthritis	0.000328	0.00156	CcSEcCtD
Carfilzomib—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000328	0.00156	CcSEcCtD
Carfilzomib—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000328	0.00156	CcSEcCtD
Carfilzomib—Infection—Prednisone—rheumatoid arthritis	0.000326	0.00155	CcSEcCtD
Carfilzomib—Back pain—Methotrexate—rheumatoid arthritis	0.000325	0.00154	CcSEcCtD
Carfilzomib—Fatigue—Betamethasone—rheumatoid arthritis	0.000325	0.00154	CcSEcCtD
Carfilzomib—Fatigue—Dexamethasone—rheumatoid arthritis	0.000325	0.00154	CcSEcCtD
Carfilzomib—Pain—Betamethasone—rheumatoid arthritis	0.000322	0.00153	CcSEcCtD
Carfilzomib—Pain—Dexamethasone—rheumatoid arthritis	0.000322	0.00153	CcSEcCtD
Carfilzomib—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000317	0.0015	CcSEcCtD
Carfilzomib—Vomiting—Cyclosporine—rheumatoid arthritis	0.000316	0.0015	CcSEcCtD
Carfilzomib—Anorexia—Prednisone—rheumatoid arthritis	0.000313	0.00149	CcSEcCtD
Carfilzomib—Headache—Cyclosporine—rheumatoid arthritis	0.000311	0.00148	CcSEcCtD
Carfilzomib—Anaemia—Methotrexate—rheumatoid arthritis	0.000311	0.00147	CcSEcCtD
Carfilzomib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000302	0.00143	CcSEcCtD
Carfilzomib—Leukopenia—Methotrexate—rheumatoid arthritis	0.000301	0.00143	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Hydrocortisone—rheumatoid arthritis	0.000301	0.0223	CbGdCrCtD
Carfilzomib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000299	0.00142	CcSEcCtD
Carfilzomib—Dizziness—Prednisolone—rheumatoid arthritis	0.000299	0.00142	CcSEcCtD
Carfilzomib—Asthenia—Triamcinolone—rheumatoid arthritis	0.000298	0.00141	CcSEcCtD
Carfilzomib—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000298	0.00141	CcSEcCtD
Carfilzomib—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000298	0.00141	CcSEcCtD
Carfilzomib—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000297	0.00141	CcSEcCtD
Carfilzomib—Insomnia—Prednisone—rheumatoid arthritis	0.000297	0.00141	CcSEcCtD
Carfilzomib—Nausea—Cyclosporine—rheumatoid arthritis	0.000295	0.0014	CcSEcCtD
Carfilzomib—Cough—Methotrexate—rheumatoid arthritis	0.000293	0.00139	CcSEcCtD
Carfilzomib—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000292	0.00138	CcSEcCtD
Carfilzomib—Arthralgia—Methotrexate—rheumatoid arthritis	0.000286	0.00136	CcSEcCtD
Carfilzomib—Decreased appetite—Prednisone—rheumatoid arthritis	0.000285	0.00135	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Methylprednisolone—rheumatoid arthritis	0.000284	0.021	CbGdCrCtD
Carfilzomib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000284	0.00135	CcSEcCtD
Carfilzomib—Fatigue—Prednisone—rheumatoid arthritis	0.000283	0.00134	CcSEcCtD
Carfilzomib—Headache—Prednisolone—rheumatoid arthritis	0.000283	0.00134	CcSEcCtD
Carfilzomib—Constipation—Prednisone—rheumatoid arthritis	0.000281	0.00133	CcSEcCtD
Carfilzomib—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000281	0.00133	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Dexamethasone—rheumatoid arthritis	0.000279	0.0207	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Betamethasone—rheumatoid arthritis	0.000279	0.0207	CbGdCrCtD
Carfilzomib—Headache—Hydrocortisone—rheumatoid arthritis	0.000276	0.00131	CcSEcCtD
Carfilzomib—Dizziness—Triamcinolone—rheumatoid arthritis	0.000275	0.0013	CcSEcCtD
Carfilzomib—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000274	0.0013	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Triamcinolone—rheumatoid arthritis	0.000273	0.0202	CbGdCrCtD
Carfilzomib—Infection—Methotrexate—rheumatoid arthritis	0.000273	0.00129	CcSEcCtD
Carfilzomib—Asthenia—Betamethasone—rheumatoid arthritis	0.00027	0.00128	CcSEcCtD
Carfilzomib—Asthenia—Dexamethasone—rheumatoid arthritis	0.00027	0.00128	CcSEcCtD
Carfilzomib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000269	0.00128	CcSEcCtD
Carfilzomib—Nausea—Prednisolone—rheumatoid arthritis	0.000268	0.00127	CcSEcCtD
Carfilzomib—Vomiting—Triamcinolone—rheumatoid arthritis	0.000264	0.00125	CcSEcCtD
Carfilzomib—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000264	0.00125	CcSEcCtD
Carfilzomib—Nausea—Hydrocortisone—rheumatoid arthritis	0.000262	0.00124	CcSEcCtD
Carfilzomib—Anorexia—Methotrexate—rheumatoid arthritis	0.000262	0.00124	CcSEcCtD
Carfilzomib—Headache—Triamcinolone—rheumatoid arthritis	0.00026	0.00124	CcSEcCtD
Carfilzomib—Headache—Methylprednisolone—rheumatoid arthritis	0.00026	0.00123	CcSEcCtD
Carfilzomib—Body temperature increased—Prednisone—rheumatoid arthritis	0.00026	0.00123	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisone—rheumatoid arthritis	0.000259	0.0192	CbGdCrCtD
Carfilzomib—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000258	0.00122	CcSEcCtD
Carfilzomib—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000258	0.00122	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisolone—rheumatoid arthritis	0.000253	0.0187	CbGdCrCtD
Carfilzomib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.00025	0.00119	CcSEcCtD
Carfilzomib—Dizziness—Dexamethasone—rheumatoid arthritis	0.000249	0.00118	CcSEcCtD
Carfilzomib—Dizziness—Betamethasone—rheumatoid arthritis	0.000249	0.00118	CcSEcCtD
Carfilzomib—Insomnia—Methotrexate—rheumatoid arthritis	0.000248	0.00118	CcSEcCtD
Carfilzomib—Nausea—Triamcinolone—rheumatoid arthritis	0.000247	0.00117	CcSEcCtD
Carfilzomib—Nausea—Methylprednisolone—rheumatoid arthritis	0.000246	0.00117	CcSEcCtD
Carfilzomib—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000245	0.00116	CcSEcCtD
Carfilzomib—Vomiting—Dexamethasone—rheumatoid arthritis	0.00024	0.00114	CcSEcCtD
Carfilzomib—Vomiting—Betamethasone—rheumatoid arthritis	0.00024	0.00114	CcSEcCtD
Carfilzomib—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000238	0.00113	CcSEcCtD
Carfilzomib—Fatigue—Methotrexate—rheumatoid arthritis	0.000237	0.00112	CcSEcCtD
Carfilzomib—Headache—Dexamethasone—rheumatoid arthritis	0.000236	0.00112	CcSEcCtD
Carfilzomib—Headache—Betamethasone—rheumatoid arthritis	0.000236	0.00112	CcSEcCtD
Carfilzomib—Asthenia—Prednisone—rheumatoid arthritis	0.000236	0.00112	CcSEcCtD
Carfilzomib—Pain—Methotrexate—rheumatoid arthritis	0.000235	0.00111	CcSEcCtD
Carfilzomib—PSMB8—Testosterone Propionate—Hydrocortisone—rheumatoid arthritis	0.000231	0.0171	CbGdCrCtD
Carfilzomib—Diarrhoea—Prednisone—rheumatoid arthritis	0.000225	0.00107	CcSEcCtD
Carfilzomib—Nausea—Betamethasone—rheumatoid arthritis	0.000224	0.00106	CcSEcCtD
Carfilzomib—Nausea—Dexamethasone—rheumatoid arthritis	0.000224	0.00106	CcSEcCtD
Carfilzomib—Dizziness—Prednisone—rheumatoid arthritis	0.000217	0.00103	CcSEcCtD
Carfilzomib—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000217	0.00103	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Methylprednisolone—rheumatoid arthritis	0.000216	0.016	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Betamethasone—rheumatoid arthritis	0.000213	0.0157	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Dexamethasone—rheumatoid arthritis	0.000213	0.0157	CbGdCrCtD
Carfilzomib—Vomiting—Prednisone—rheumatoid arthritis	0.000209	0.000991	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Triamcinolone—rheumatoid arthritis	0.000208	0.0154	CbGdCrCtD
Carfilzomib—Headache—Prednisone—rheumatoid arthritis	0.000206	0.000976	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Prednisone—rheumatoid arthritis	0.000197	0.0146	CbGdCrCtD
Carfilzomib—Asthenia—Methotrexate—rheumatoid arthritis	0.000197	0.000934	CcSEcCtD
Carfilzomib—Nausea—Prednisone—rheumatoid arthritis	0.000195	0.000926	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Prednisolone—rheumatoid arthritis	0.000192	0.0143	CbGdCrCtD
Carfilzomib—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000188	0.000891	CcSEcCtD
Carfilzomib—Dizziness—Methotrexate—rheumatoid arthritis	0.000181	0.000861	CcSEcCtD
Carfilzomib—Vomiting—Methotrexate—rheumatoid arthritis	0.000174	0.000828	CcSEcCtD
Carfilzomib—PSMB8—Norethindrone—Hydrocortisone—rheumatoid arthritis	0.000173	0.0128	CbGdCrCtD
Carfilzomib—Headache—Methotrexate—rheumatoid arthritis	0.000172	0.000816	CcSEcCtD
Carfilzomib—Nausea—Methotrexate—rheumatoid arthritis	0.000163	0.000774	CcSEcCtD
Carfilzomib—PSMB8—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.000138	0.0102	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.000123	0.00909	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.000123	0.00909	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.000116	0.00858	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.000116	0.00858	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000114	0.00845	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000114	0.00845	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Triamcinolone—rheumatoid arthritis	0.000111	0.00825	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Triamcinolone—rheumatoid arthritis	0.000111	0.00825	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Prednisone—rheumatoid arthritis	0.000106	0.00783	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisone—rheumatoid arthritis	0.000106	0.00783	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Prednisolone—rheumatoid arthritis	0.000103	0.00764	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisolone—rheumatoid arthritis	0.000103	0.00764	CbGdCrCtD
Carfilzomib—PSMB2—Signaling Pathways—PTK2—rheumatoid arthritis	3.09e-05	7.15e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FN1—rheumatoid arthritis	3.09e-05	7.15e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6ST—rheumatoid arthritis	3.08e-05	7.12e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FN1—rheumatoid arthritis	3.07e-05	7.12e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ALB—rheumatoid arthritis	3.07e-05	7.1e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6ST—rheumatoid arthritis	3.06e-05	7.09e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ALB—rheumatoid arthritis	3.05e-05	7.07e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GC—rheumatoid arthritis	3.05e-05	7.06e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGES—rheumatoid arthritis	3.05e-05	7.06e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PTK2—rheumatoid arthritis	3.05e-05	7.05e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL5—rheumatoid arthritis	3.03e-05	7.01e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL5—rheumatoid arthritis	3.03e-05	7.01e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL5—rheumatoid arthritis	3.03e-05	7.01e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—NFKB1—rheumatoid arthritis	3.01e-05	6.97e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—NFKB1—rheumatoid arthritis	3e-05	6.94e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCL5—rheumatoid arthritis	2.99e-05	6.91e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CSF2—rheumatoid arthritis	2.98e-05	6.91e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CSF2—rheumatoid arthritis	2.98e-05	6.91e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CSF2—rheumatoid arthritis	2.98e-05	6.91e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6R—rheumatoid arthritis	2.97e-05	6.88e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6R—rheumatoid arthritis	2.97e-05	6.88e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6R—rheumatoid arthritis	2.97e-05	6.88e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—MAPK8—rheumatoid arthritis	2.96e-05	6.86e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CD80—rheumatoid arthritis	2.96e-05	6.85e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—MAPK8—rheumatoid arthritis	2.95e-05	6.82e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CD80—rheumatoid arthritis	2.95e-05	6.82e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CSF2—rheumatoid arthritis	2.94e-05	6.81e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—NOS3—rheumatoid arthritis	2.93e-05	6.79e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—TYK2—rheumatoid arthritis	2.93e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—TYK2—rheumatoid arthritis	2.93e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—TYK2—rheumatoid arthritis	2.93e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6R—rheumatoid arthritis	2.93e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—NOS3—rheumatoid arthritis	2.92e-05	6.76e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—TYK2—rheumatoid arthritis	2.89e-05	6.69e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLB1—rheumatoid arthritis	2.84e-05	6.56e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—rheumatoid arthritis	2.82e-05	6.52e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—rheumatoid arthritis	2.82e-05	6.52e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—rheumatoid arthritis	2.82e-05	6.52e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—POMC—rheumatoid arthritis	2.81e-05	6.51e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SPP1—rheumatoid arthritis	2.81e-05	6.49e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SPP1—rheumatoid arthritis	2.81e-05	6.49e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SPP1—rheumatoid arthritis	2.81e-05	6.49e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—POMC—rheumatoid arthritis	2.8e-05	6.48e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	2.79e-05	6.46e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—rheumatoid arthritis	2.78e-05	6.43e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SPP1—rheumatoid arthritis	2.77e-05	6.4e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCL2—rheumatoid arthritis	2.75e-05	6.37e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	2.75e-05	6.35e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6R—rheumatoid arthritis	2.75e-05	6.35e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—rheumatoid arthritis	2.74e-05	6.35e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—rheumatoid arthritis	2.74e-05	6.35e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—rheumatoid arthritis	2.74e-05	6.35e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCL2—rheumatoid arthritis	2.74e-05	6.34e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6R—rheumatoid arthritis	2.73e-05	6.32e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCR5—rheumatoid arthritis	2.73e-05	6.32e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCR5—rheumatoid arthritis	2.73e-05	6.32e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCR5—rheumatoid arthritis	2.73e-05	6.32e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TYK2—rheumatoid arthritis	2.71e-05	6.26e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TYK2—rheumatoid arthritis	2.71e-05	6.26e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TYK2—rheumatoid arthritis	2.71e-05	6.26e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—rheumatoid arthritis	2.71e-05	6.26e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCR5—rheumatoid arthritis	2.69e-05	6.23e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2RA—rheumatoid arthritis	2.69e-05	6.22e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2RA—rheumatoid arthritis	2.69e-05	6.22e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2RA—rheumatoid arthritis	2.69e-05	6.22e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—rheumatoid arthritis	2.68e-05	6.21e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—rheumatoid arthritis	2.67e-05	6.18e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TYK2—rheumatoid arthritis	2.67e-05	6.17e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—C3—rheumatoid arthritis	2.67e-05	6.17e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—C3—rheumatoid arthritis	2.67e-05	6.17e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—C3—rheumatoid arthritis	2.67e-05	6.17e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS3—rheumatoid arthritis	2.66e-05	6.15e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS3—rheumatoid arthritis	2.66e-05	6.15e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS3—rheumatoid arthritis	2.66e-05	6.15e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2RA—rheumatoid arthritis	2.65e-05	6.14e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—rheumatoid arthritis	2.65e-05	6.13e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—rheumatoid arthritis	2.65e-05	6.13e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—rheumatoid arthritis	2.65e-05	6.13e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—C3—rheumatoid arthritis	2.63e-05	6.08e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS3—rheumatoid arthritis	2.62e-05	6.06e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—rheumatoid arthritis	2.61e-05	6.05e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—POMC—rheumatoid arthritis	2.55e-05	5.9e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—POMC—rheumatoid arthritis	2.55e-05	5.9e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—POMC—rheumatoid arthritis	2.55e-05	5.9e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	2.53e-05	5.87e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—POMC—rheumatoid arthritis	2.51e-05	5.82e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TYK2—rheumatoid arthritis	2.5e-05	5.79e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TYK2—rheumatoid arthritis	2.49e-05	5.76e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MED1—rheumatoid arthritis	2.49e-05	5.76e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—LEP—rheumatoid arthritis	2.48e-05	5.75e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—LEP—rheumatoid arthritis	2.48e-05	5.75e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—LEP—rheumatoid arthritis	2.48e-05	5.75e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NOS3—rheumatoid arthritis	2.45e-05	5.68e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—rheumatoid arthritis	2.45e-05	5.67e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—rheumatoid arthritis	2.45e-05	5.67e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—rheumatoid arthritis	2.45e-05	5.67e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—LEP—rheumatoid arthritis	2.45e-05	5.66e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—rheumatoid arthritis	2.45e-05	5.66e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—rheumatoid arthritis	2.45e-05	5.66e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—rheumatoid arthritis	2.45e-05	5.66e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NOS3—rheumatoid arthritis	2.44e-05	5.65e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—rheumatoid arthritis	2.44e-05	5.64e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—rheumatoid arthritis	2.44e-05	5.64e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—rheumatoid arthritis	2.44e-05	5.64e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—rheumatoid arthritis	2.43e-05	5.62e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—rheumatoid arthritis	2.43e-05	5.62e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—rheumatoid arthritis	2.43e-05	5.62e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—rheumatoid arthritis	2.41e-05	5.59e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—rheumatoid arthritis	2.41e-05	5.58e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—rheumatoid arthritis	2.4e-05	5.56e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—rheumatoid arthritis	2.39e-05	5.54e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FN1—rheumatoid arthritis	2.34e-05	5.42e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FN1—rheumatoid arthritis	2.34e-05	5.42e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FN1—rheumatoid arthritis	2.34e-05	5.42e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6ST—rheumatoid arthritis	2.33e-05	5.4e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6ST—rheumatoid arthritis	2.33e-05	5.4e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6ST—rheumatoid arthritis	2.33e-05	5.4e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	2.33e-05	5.39e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALB—rheumatoid arthritis	2.33e-05	5.38e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALB—rheumatoid arthritis	2.33e-05	5.38e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALB—rheumatoid arthritis	2.33e-05	5.38e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—TGFB1—rheumatoid arthritis	2.32e-05	5.36e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	2.31e-05	5.35e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ACP5—rheumatoid arthritis	2.31e-05	5.35e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FN1—rheumatoid arthritis	2.31e-05	5.34e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—TGFB1—rheumatoid arthritis	2.31e-05	5.34e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6ST—rheumatoid arthritis	2.3e-05	5.32e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALB—rheumatoid arthritis	2.29e-05	5.31e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—NFKB1—rheumatoid arthritis	2.28e-05	5.29e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—NFKB1—rheumatoid arthritis	2.28e-05	5.29e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—NFKB1—rheumatoid arthritis	2.28e-05	5.29e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—NFKB1—rheumatoid arthritis	2.25e-05	5.21e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—MAPK8—rheumatoid arthritis	2.24e-05	5.2e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—MAPK8—rheumatoid arthritis	2.24e-05	5.2e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—MAPK8—rheumatoid arthritis	2.24e-05	5.2e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CD80—rheumatoid arthritis	2.24e-05	5.2e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CD80—rheumatoid arthritis	2.24e-05	5.2e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CD80—rheumatoid arthritis	2.24e-05	5.2e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NOS3—rheumatoid arthritis	2.22e-05	5.15e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NOS3—rheumatoid arthritis	2.22e-05	5.15e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NOS3—rheumatoid arthritis	2.22e-05	5.15e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—MAPK8—rheumatoid arthritis	2.21e-05	5.12e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CD80—rheumatoid arthritis	2.21e-05	5.12e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NOS3—rheumatoid arthritis	2.19e-05	5.08e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL8—rheumatoid arthritis	2.18e-05	5.04e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	2.17e-05	5.03e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL8—rheumatoid arthritis	2.17e-05	5.01e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—POMC—rheumatoid arthritis	2.13e-05	4.94e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—POMC—rheumatoid arthritis	2.13e-05	4.94e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—POMC—rheumatoid arthritis	2.13e-05	4.94e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—POMC—rheumatoid arthritis	2.1e-05	4.87e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL2—rheumatoid arthritis	2.09e-05	4.83e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL2—rheumatoid arthritis	2.09e-05	4.83e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL2—rheumatoid arthritis	2.09e-05	4.83e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—BGN—rheumatoid arthritis	2.08e-05	4.82e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6R—rheumatoid arthritis	2.08e-05	4.82e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6R—rheumatoid arthritis	2.08e-05	4.82e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6R—rheumatoid arthritis	2.08e-05	4.82e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2—rheumatoid arthritis	2.08e-05	4.82e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—rheumatoid arthritis	2.07e-05	4.79e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCL2—rheumatoid arthritis	2.06e-05	4.76e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6R—rheumatoid arthritis	2.05e-05	4.75e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—rheumatoid arthritis	2.03e-05	4.71e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—rheumatoid arthritis	2.03e-05	4.71e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—rheumatoid arthritis	2.03e-05	4.71e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—rheumatoid arthritis	2.01e-05	4.64e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—rheumatoid arthritis	1.97e-05	4.56e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—rheumatoid arthritis	1.96e-05	4.54e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NFKB1—rheumatoid arthritis	1.95e-05	4.51e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NFKB1—rheumatoid arthritis	1.94e-05	4.49e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	1.92e-05	4.43e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.92e-05	4.43e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MAPK8—rheumatoid arthritis	1.91e-05	4.43e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MAPK8—rheumatoid arthritis	1.91e-05	4.41e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TYK2—rheumatoid arthritis	1.89e-05	4.39e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TYK2—rheumatoid arthritis	1.89e-05	4.39e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TYK2—rheumatoid arthritis	1.89e-05	4.39e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—rheumatoid arthritis	1.89e-05	4.38e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—rheumatoid arthritis	1.88e-05	4.36e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TYK2—rheumatoid arthritis	1.87e-05	4.32e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—rheumatoid arthritis	1.86e-05	4.3e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—rheumatoid arthritis	1.86e-05	4.3e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—rheumatoid arthritis	1.86e-05	4.3e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—rheumatoid arthritis	1.83e-05	4.24e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—rheumatoid arthritis	1.77e-05	4.09e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—rheumatoid arthritis	1.76e-05	4.07e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—rheumatoid arthritis	1.76e-05	4.06e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—rheumatoid arthritis	1.76e-05	4.06e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—rheumatoid arthritis	1.76e-05	4.06e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—rheumatoid arthritis	1.75e-05	4.04e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—rheumatoid arthritis	1.74e-05	4.02e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—rheumatoid arthritis	1.73e-05	4.01e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL8—rheumatoid arthritis	1.65e-05	3.82e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.65e-05	3.82e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.65e-05	3.82e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL8—rheumatoid arthritis	1.63e-05	3.76e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—rheumatoid arthritis	1.62e-05	3.76e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—rheumatoid arthritis	1.61e-05	3.74e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2—rheumatoid arthritis	1.58e-05	3.65e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—rheumatoid arthritis	1.58e-05	3.65e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—rheumatoid arthritis	1.58e-05	3.65e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ENO1—rheumatoid arthritis	1.56e-05	3.61e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2—rheumatoid arthritis	1.55e-05	3.6e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—rheumatoid arthritis	1.49e-05	3.45e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—rheumatoid arthritis	1.49e-05	3.45e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—rheumatoid arthritis	1.49e-05	3.45e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.48e-05	3.42e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NFKB1—rheumatoid arthritis	1.48e-05	3.42e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.48e-05	3.42e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—rheumatoid arthritis	1.47e-05	3.41e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.46e-05	3.38e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NFKB1—rheumatoid arthritis	1.46e-05	3.37e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MAPK8—rheumatoid arthritis	1.45e-05	3.36e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.45e-05	3.36e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.45e-05	3.36e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—rheumatoid arthritis	1.43e-05	3.32e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—rheumatoid arthritis	1.43e-05	3.32e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—rheumatoid arthritis	1.43e-05	3.32e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MAPK8—rheumatoid arthritis	1.43e-05	3.31e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—rheumatoid arthritis	1.41e-05	3.27e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.34e-05	3.1e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—rheumatoid arthritis	1.34e-05	3.1e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.34e-05	3.1e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—rheumatoid arthritis	1.34e-05	3.09e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—rheumatoid arthritis	1.33e-05	3.08e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—rheumatoid arthritis	1.32e-05	3.06e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—rheumatoid arthritis	1.32e-05	3.06e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—rheumatoid arthritis	1.32e-05	3.06e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—rheumatoid arthritis	1.32e-05	3.06e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—rheumatoid arthritis	1.3e-05	3.02e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.23e-05	2.85e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—rheumatoid arthritis	1.23e-05	2.85e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.23e-05	2.85e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—rheumatoid arthritis	1.22e-05	2.83e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—rheumatoid arthritis	1.22e-05	2.82e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—rheumatoid arthritis	1.21e-05	2.81e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CAT—rheumatoid arthritis	1.12e-05	2.6e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—rheumatoid arthritis	1.01e-05	2.34e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—rheumatoid arthritis	1.01e-05	2.34e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—rheumatoid arthritis	1.01e-05	2.34e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—rheumatoid arthritis	9.98e-06	2.31e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	9.38e-06	2.17e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—rheumatoid arthritis	9.27e-06	2.14e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—rheumatoid arthritis	9.27e-06	2.14e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—rheumatoid arthritis	9.27e-06	2.14e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—rheumatoid arthritis	9.14e-06	2.11e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—POMC—rheumatoid arthritis	7.5e-06	1.74e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—rheumatoid arthritis	6.84e-06	1.58e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—rheumatoid arthritis	6.54e-06	1.51e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	5.98e-06	1.39e-05	CbGpPWpGaD
